Hers vs Ryze Rx
Hers and Ryze Rx both sell semaglutide and tirzepatide; this is how their prices, coverage and records differ.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Hers
Best for: coverage in all 50 states, which most sellers will not confirm
Visit Hers →
Ryze Rx
Best for: seeing what it charges before you answer any medical questions
Visit Ryze Rx →If you are choosing between Hers and Ryze Rx, price alone will not settle it. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. They tie at 6.6 on our six-part score. One of the two has an FDA warning letter on record, covered below.
Hers vs Ryze Rx price
Hers and Ryze Rx start at the same figure, $199 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.
Drug by drug: Semaglutide costs the same at both, $199 a month; tirzepatide is cheaper at Ryze Rx ($199 a month vs $299 a month).
Medications and formats
Both sell semaglutide and tirzepatide.
On format, Hers prices compounded injections and brand-name pens, while Ryze Rx prices compounded injections.
If you want the FDA-approved brand rather than a compounded version, Hers is the only one of the two with a brand-name price.
Where each one treats patients
Hers lists 50 states, and Ryze Rx does not publish where it ships.
Pricing
Hers
Brand Zepbound from $299/mo medication-only; requires Hers Weight Loss Membership ($149/mo)
Ryze Rx
Injectable semaglutide: $199 for 1 month or $499 for a 3-month bundle. The homepage headline of 'from $149/mo' does not match any listed plan.
Injectable tirzepatide: $199 for 1 month or $799 for a 3-month bundle.
What each price covers
Both prices cover the medication itself.
Ryze Rx's price also covers the clinician visit and shipping, which Hers does not claim.
Hers is silent on shipping and lab work.
Ryze Rx is silent on lab work and coaching.
Hers
Covered by the monthly price
Medication
In the price
Clinician visits
Charged on top
Shipping
Not stated
Lab work
Not stated
Coaching
Charged on top
Ryze Rx
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Where each one scores higher
Overall they tie at 6.6 out of 10.
Hers is stronger on accessibility (10.0 vs 5.0).
Ryze Rx is stronger on trust & safety (6.5 vs 5.5) and support (7.0 vs 3.0).
Value, effectiveness and user experience are within half a point.
Hers
6.6/10
Ryze Rx
6.6/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent Hers a warning letter dated September 9, 2025 (letter 716825), and it is still open.
Ryze Rx has no FDA warning letter on record with us.
Features & Coverage
| Feature | Hers | Ryze Rx |
|---|---|---|
| Starting Price | $199/mo | $199/mo |
| Features | 2 features | ✓5 features |
| States Available | 50 | Not disclosed |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | 1 letter | ✓None |
About Hers
Hers is the women-focused telehealth brand from Hims and Hers. It sells compounded semaglutide on a 6-month plan.
Read our full Hers review →About Ryze Rx
Ryze Rx prices compounded injectable semaglutide and tirzepatide at $199/mo, or $499 and $799 for a 3-month bundle, with the physician consult and shipping included. Board-certified physicians prescribe and US-licensed compounding pharmacies ship. The platform also covers TRT and peptide therapy. Its homepage advertises care in all 50 states.
Read our full Ryze Rx review →Pros & Cons
Hers
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication
- Serves all 50 states
Watch-outs
- Not included in the monthly price: clinician visits, coaching
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- The FDA has issued Hers a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Ryze Rx
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits and shipping
- We found no FDA warning letters issued to Ryze Rx
Watch-outs
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Hers and Ryze Rx finish level at 6.6. Choose on the state list and on what each monthly price covers.
Choose Hers if…
You want coverage in all 50 states, which most sellers will not confirm and an opening price near $199 a month.
Choose Ryze Rx if…
You want seeing what it charges before you answer any medical questions and an opening price near $199 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
bmiMD
Starting below a standard dose, with microdose tiers
From $99/mo
Get started →RxSpan MD
Knowing which pharmacy fills the vial: it names Belmar Pharmacy
From $249/mo
Get started →Luvo Health
Moving between compounded and brand without changing seller
From $249/mo
Get started →Hers vs Ryze Rx: FAQ
Close alternatives to Hers and Ryze Rx
- Hers vs Hims
- Hers vs Care Bare Rx
- Hers vs Concierge MD LA
- Hers vs Corsica Health
- Ryze Rx vs Hims
- Ryze Rx vs Curex
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.